devdiscourse1d
FDA's Game-Changing Approvals and Global Health Alerts
The latest health news highlights FDA's approval of BridgeBio's drug for a rare heart condition, cancer features in healthy ...
“No magic wand” for Novo Nordisk, as CagriSema pen supply rumours swirl
Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.
Novo Nordisk said to have contracted Ypsomed to make next gen obesity drug’s pens
Novo Nordisk's (NVO) contract Ypsomed to supply the company with injection pens designed to deliver its next-gen obesity ...
Ypsomed will make injection pens for Novo Nordisk's CagriSema, source says
Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish drugmaker's next-generation experimental obesity drug CagriSema, a source ...
Ypsomed will make injection pens for Novo Nordisk's CagriSema, says source
Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish ...
ENDPOINTS NEWS2d
At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s
The Jefferies London Healthcare Conference at Waldorf Hilton drew thousands, focusing heavily on GLP-1 manufacturing. Notable ...
Jazz Pharmaceuticals receives FDA approval for biliary tract cancer treatment
The U.S. Food and Drug Administration approved Jazz Pharmaceuticals' drug, zanidatamab-hrii, for the treatment of a type of ...